| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.8B | $4.7B | $1.4B | $8.5B | $7.1B | $8.5B | $0.3B | $4.0B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.4B | $0.4B | $-0.9B | $0.0B | $-0.1B | $-1.1B | $-1.1B | $1.4B |
| EPS (Basic) | $5.75 | $4.67 | $-14.70 | $-1.36 | $-2.36 | $-11.58 | $-10.02 | $12.18 |
| EPS (Diluted) | $5.71 | $4.64 | $-14.70 | $-1.36 | $-2.36 | $-11.58 | $-10.02 | $12.14 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $241.8B | $238.5B | $236.3B | $225.6B | $259.8B | $247.9B | $227.3B | $206.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | $4.5B | $4.1B | $2.9B | $4.1B |
| Total Liabilities | $235.0B | $233.5B | $231.3B | $219.5B | $243.6B | $229.8B | $211.0B | $191.8B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $6.8B | $5.0B | $4.9B | $6.0B | $16.1B | $18.0B | $16.2B | $14.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $-0.3B | $-0.1B | $-1.2B | $0.7B | $0.9B | $1.8B | $3.1B |
| Investing Cash Flow | $0.8B | $-2.2B | $-3.2B | $-8.3B | $-12.2B | $-5.8B | $-7.3B | $-4.5B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-0.7B | $3.7B | $3.1B | $9.1B | $11.9B | $6.2B | $4.2B | $3.8B |